亿帆医药
(002019)
| 流通市值：78.86亿 | | | 总市值：113.85亿 |
| 流通股本：8.43亿 | | | 总股本：12.16亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,467,572,376.09 | 1,255,507,032.81 | 5,132,949,329.53 | 3,922,709,366.04 |
| 营业总成本 | 2,194,461,836.94 | 1,119,394,963.51 | 4,696,113,393.72 | 3,507,090,512.56 |
| 其他经营收益 | | | | |
| 营业利润 | 230,346,682.79 | 120,067,266.08 | 428,644,889.8 | 435,706,848.84 |
| 利润总额 | 229,282,142.47 | 120,862,479.85 | 423,704,237.46 | 434,810,968.73 |
| 净利润 | 187,392,598.33 | 95,712,723.84 | 373,451,729.24 | 360,252,018.99 |
| 每股收益 | | | | |
| 其他综合收益 | -70,765,756.86 | -45,377,158.2 | 29,928,782.62 | 40,735,013.03 |
| 综合收益总额 | 116,626,841.47 | 50,335,565.64 | 403,380,511.86 | 400,987,032.02 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,894,048,820.13 | 3,867,192,019.03 | 3,921,887,791.24 | 4,313,556,790.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,993,618,901.51 | 8,978,072,598.73 | 8,923,116,422.45 | 8,792,601,286.98 |
| 资产总计 | 12,887,667,721.64 | 12,845,264,617.76 | 12,845,004,213.69 | 13,106,158,077.09 |
| 流动负债: | | | | |
| 流动负债合计 | 3,019,540,439.53 | 2,891,988,690.22 | 3,033,045,515.32 | 3,401,229,033.15 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,181,621,881.85 | 1,192,314,763.15 | 1,100,973,007.83 | 996,514,670.64 |
| 负债合计 | 4,201,162,321.38 | 4,084,303,453.37 | 4,134,018,523.15 | 4,397,743,703.79 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,847,213,570.27 | 8,895,654,773.76 | 8,834,531,174.79 | 8,831,073,964.25 |
| 股东权益合计 | 8,686,505,400.26 | 8,760,961,164.39 | 8,710,985,690.54 | 8,708,414,373.3 |
| 负债和股东权益合计 | 12,887,667,721.64 | 12,845,264,617.76 | 12,845,004,213.69 | 13,106,158,077.09 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,665,960,465.25 | 1,367,875,704.74 | 5,356,115,263.58 | 4,051,201,019.43 |
| 经营活动现金流出小计 | 2,072,450,401.11 | 1,083,037,487 | 4,897,748,978.75 | 3,725,050,032.14 |
| 经营活动产生的现金流量净额 | 593,510,064.14 | 284,838,217.74 | 458,366,284.83 | 326,150,987.29 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 62,064,427.99 | 8,999,530.41 | 105,137,190.17 | 89,640,198.91 |
| 投资活动现金流出小计 | 427,167,958.5 | 215,715,287.35 | 559,232,140.2 | 434,009,680.76 |
| 投资活动产生的现金流量净额 | -365,103,530.51 | -206,715,756.94 | -454,094,950.03 | -344,369,481.85 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 716,542,199.26 | 361,846,346.49 | 1,857,956,837.59 | 1,618,903,373.48 |
| 筹资活动现金流出小计 | 774,773,590.83 | 359,029,848.98 | 1,972,128,315.4 | 1,564,916,299.29 |
| 筹资活动产生的现金流量净额 | -58,231,391.57 | 2,816,497.51 | -114,171,477.81 | 53,987,074.19 |
| 汇率变动对现金及现金等价物的影响 | -24,481,532.3 | -14,429,757.72 | -3,969,598.42 | -2,301,795.45 |
| 现金及现金等价物净增加额 | 145,693,609.76 | 66,509,200.59 | -113,869,741.43 | 33,466,784.18 |
| 期末现金及现金等价物余额 | 809,461,726.23 | 730,277,317.06 | 663,768,116.47 | 811,104,642.08 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 145,693,609.76 | - | -113,869,741.43 | - |
最新报告期：2026-09-21| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 首创证券 | 王斌 | 0.35 | 0.44 | 0.52 | 2026-09-21 |